Alendronate Prevents Loss of Bone Density Associated With Discontinuation of Hormone Replacement Therapy
Archives of Internal Medicine
doi 10.1001/archinte.163.7.789
Full Text
Open PDFAbstract
Available in full text
Date
April 14, 2003
Authors
Publisher
American Medical Association (AMA)